ANNX Annexon Buxgalteriya kapitallashuvi

Ommaviy kompaniya Annexon (ANNX) logotipi

Annexon, Inc. (ANNX) ilg'or komplement tizimi inhibitsiyasi terapiyalarining yakuniy kengaytirish bosqichiga e'tibor qaratmoqda. Rahbariyat nevrologiya va oftalmologiya dori vositalarining validatsiyasini tezlashtirish uchun investitsiyalarni samarali taqsimlamoqda. Biznes moddalar sintezi va sinovlari uchun tashqi pudratchilarga tayanadi va 0.19 ko'rsatkichi GURU.Markets platformasidagi xarajatlar tendentsiyasini aks ettiruvchi narxlar grafigida ko'rinib turibdi.

ANNX Annexon Balans kapitallashuvi (04.07.2022 - 27.10.2026)

Annexon (ANNX) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi Annexon Biosciences Inc.|ANNX - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Annexon, Inc.|ANNX - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Annexon|ANNX - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti annexonbio.com|ANNX - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Annexon, Inc.|ANNX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Annexon Biosciences|ANNX - Kompaniya qarzlari|Balans qiymatiga qarzlar Annexon, Inc.
Kompaniyaning jamlanma tahlili:ANNX - Annexon Biosciences Inc.
Annexon Biosciences yetakchi tovari

Annexon, Inc. (ANNX) kompaniyasining operatsiyalar ko'lami biotexnologiya sektoridagi intellektual aktivlarining qiymati bilan belgilanadi. Kitob kapitalizatsiyasi aksiyaning real qiymatini o'lchash uchun hisobot ma'lumotlarini bozor narxi bilan sintez qiladi. Investorlar qarz yukining kapitalga ta'sirini tahlil qilish orqali fundamental kuchni bozor shovqinlaridan ajratadilar. Dori vositalarini ishlab chiqishning nodavriy tabiati tufayli, ushbu metrika retsessiyaga chidamlilikni namoyish etadi. Kitob kapitalizatsiyasi harakatining ushbu grafigi biznesning ichki barqarorligini tasdiqlaydi.

Annexon, Inc. raqobatchilari tahlili

Biogen Idec (BIIB) - Buxgalteriya kapitallashuvi|Kompaniyaning sof aktivlari Neurocrine Biosciences|RGC (regencellbioscience.com) - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|Amylyx Corp (AMLX) - Kompaniyaning xususiy kapitali|TRVI (Trevi Therapeutics) - Balans kapitallashuvi|Balans kapitallashuvi PRAX|Kompaniyaning balans qiymati Anavex Life Sciences Corp. AVXL|Buxgalteriya kapitallashuvi CBLL (CeriBell Inc)|PRTA - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi Alector Inc. ALEC|OMER (Omeros Corp.) - Balans kapitallashuvi|neurogene.com (NGNE) - Kompaniyaning xususiy kapitali|Kompaniyaning sof aktivlari AC Immune SA|VYGR (Voyager Therapeutics Inc) - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati NMRA (Neumora Therapeutics Inc)|Kompaniyaning xususiy kapitali SCLX|Kompaniyaning balans qiymati Tevogen Bio Holdings TVGN|Buxgalteriya kapitallashuvi alphacognition.com ACOG|Kompaniyaning sof aktivlari Cognition Therapeutics|Kompaniyaning buxgalteriya qiymati Inhibikase Therapeutics Inc IKT|Balans kapitallashuvi SAVA (Cassava)|ASRT: Biznesning balans bahosi|Kompaniyaning balans qiymati coyatherapeutics.com|Vistagen (VTGN) - Buxgalteriya kapitallashuvi|Balans kapitallashuvi OVID|Kompaniyaning sof aktivlari Acumen Pharmaceuticals Inc. (ABOS)|CRVO (CervoMed Inc) - Kompaniyaning sof aktivlari|Biznesning balans bahosi alteritytherapeutics.com (ATHE)|Balans kapitallashuvi CLNN (Clene)|PepGen Inc - Balans kapitallashuvi|Jupiter Neurosciences Inc (JUNS) - Kompaniyaning balans qiymati|RLMD: Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati Annovis Bio Corp|Buxgalteriya kapitallashuvi Grace Therapeutics|Kompaniyaning sof aktivlari Firefly Neuroscience, Inc (AIFF)|Buxgalteriya kapitallashuvi KLTO|Kompaniyaning balans qiymati NeuroSense Therapeutics NRSN|Buxgalteriya kapitallashuvi Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA: Balans kapitallashuvi|NRXS - Kompaniyaning xususiy kapitali|Helius Medical Technologies Inc. - Kompaniyaning sof aktivlari|PASG: Balans kapitallashuvi|Kompaniyaning balans qiymati bionomics.com.au NEUP|NERV (Minerva Neurosciences Inc) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati ATHA (Athira)|Kompaniyaning xususiy kapitali Addex|Balans kapitallashuvi ALZN|Balans kapitallashuvi CYCN (cyclerion.com)|PTIX - Kompaniyaning balans qiymati|Pasithea Therapeutics Corp - Buxgalteriya kapitallashuvi|Cortigent Medical (CRGT) - Kompaniyaning balans qiymati|ATXI - Buxgalteriya kapitallashuvi|Balans kapitallashuvi BCLI|Kompaniyaning xususiy kapitali caratherapeutics.com|Kompaniyaning sof aktivlari Chromocell Therapeutics Corp. (CHRO)|Buxgalteriya kapitallashuvi ELYM|Intra-Cellular Therapies - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali LBPH (Longboard)|MRNS - Kompaniyaning balans qiymati|NKGN - Buxgalteriya kapitallashuvi|Kompaniyaning sof aktivlari NeuroBo Pharmaceuticals, Inc. (NRBO)|SAGE - Kompaniyaning buxgalteriya qiymati|Neurotrope - Balans kapitallashuvi|TRVN (Trevena Inc) - Biznesning balans bahosi|Kompaniyaning balans qiymati Vigil Neuroscience Inc. (VIGL)|Buxgalteriya kapitallashuvi Anew Medical Inc.|Balans kapitallashuvi CERE (Cerevel Therapeutics, Inc.)